Immediate Impact
16 by Nobel laureates 20 from Science/Nature 85 standout
Citing Papers
Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis
2022 Standout
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
2021 Standout
Works of Mark H. Kagen being referenced
Blockade of CD11a by Efalizumab in Psoriasis Patients Induces a Unique State of T-Cell Hyporesponsiveness
2008
Efalizumab (anti-CD11a)-induced increase in peripheral blood leukocytes in psoriasis patients is preferentially mediated by altered trafficking of memory CD8+ T cells into lesional skin
2004
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Mark H. Kagen | 122 | 187 | 42 | 196 | 125 | 11 | 394 | |
| Luciano Mavilia | 44 | 194 | 37 | 255 | 68 | 16 | 400 | |
| Milan Tjioe | 76 | 183 | 19 | 240 | 98 | 14 | 447 | |
| Georg Popp | 56 | 161 | 18 | 298 | 121 | 10 | 451 | |
| Sophie Weatherhead | 129 | 78 | 39 | 171 | 88 | 14 | 371 | |
| Donald M. Wayte | 29 | 109 | 21 | 94 | 149 | 12 | 373 | |
| Robert H. Zax | 26 | 239 | 41 | 110 | 224 | 10 | 434 | |
| Antonio Rocamora | 37 | 78 | 48 | 195 | 212 | 11 | 381 | |
| Bernard A. Ackerman | 57 | 187 | 144 | 331 | 147 | 19 | 431 | |
| Caron Grin-Jorgensen | 24 | 139 | 28 | 139 | 283 | 11 | 383 | |
| R Rankin | 45 | 107 | 23 | 120 | 289 | 18 | 454 |
All Works
Loading papers...